These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
951 related items for PubMed ID: 33643818
1. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W, Josephson L, Meyer JH, Zhang MR, Vasdev N, Wang J, Xu H, Wang L, Liang SH. Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818 [Abstract] [Full Text] [Related]
2. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand. Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L. Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361 [Abstract] [Full Text] [Related]
3. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis. Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL. Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925 [Abstract] [Full Text] [Related]
5. Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases. Alam MM, Lee J, Lee SY. Nucl Med Mol Imaging; 2017 Dec; 51(4):283-296. PubMed ID: 29242722 [Abstract] [Full Text] [Related]
8. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort? Fan Z, Harold D, Pasqualetti G, Williams J, Brooks DJ, Edison P. J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980 [Abstract] [Full Text] [Related]
9. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. Takano A, Piehl F, Hillert J, Varrone A, Nag S, Gulyás B, Stenkrona P, Villemagne VL, Rowe CC, Macdonell R, Tawil NA, Kucinski T, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Halldin C. EJNMMI Res; 2013 Apr 24; 3(1):30. PubMed ID: 23618062 [Abstract] [Full Text] [Related]
10. Biomarkers in Parkinson's disease (recent update). Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Ojo C, Jelebinkov M, Kurdi Y, Ebadi M. Neurochem Int; 2013 Sep 24; 63(3):201-29. PubMed ID: 23791710 [Abstract] [Full Text] [Related]
14. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands. Van Weehaeghe D, Babu S, De Vocht J, Zürcher NR, Chew S, Tseng CJ, Loggia ML, Koole M, Rezaei A, Schramm G, Van Damme P, Hooker JM, Van Laere K, Atassi N. J Nucl Med; 2020 Nov 24; 61(11):1621-1627. PubMed ID: 32169920 [Abstract] [Full Text] [Related]
15. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein. Gershen LD, Zanotti-Fregonara P, Dustin IH, Liow JS, Hirvonen J, Kreisl WC, Jenko KJ, Inati SK, Fujita M, Morse CL, Brouwer C, Hong JS, Pike VW, Zoghbi SS, Innis RB, Theodore WH. JAMA Neurol; 2015 Aug 24; 72(8):882-8. PubMed ID: 26052981 [Abstract] [Full Text] [Related]